SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-144590
Filing Date
2021-11-29
Accepted
2021-11-29 19:55:13
Documents
1
Period of Report
2021-11-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2134167d1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2134167d1_4seq1.xml 4 6814
  Complete submission text file 0001104659-21-144590.txt   8464
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO, DUBLIN L2 ----
Business Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO, DUBLIN L2 ---- 353 1 901 5701
Malin Life Sciences Holdings Ltd (Reporting) CIK: 0001685138 (see all company filings)

State of Incorp.: L2 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 211457961